Advertisement

Index by author

September 01, 2013; Volume 346,Issue 3

  1. Ahnaou, Abdel

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  2. Akcay, Ali

    1. NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury
      Hyun-Jung Kim, Dong Won Lee, Kameswaran Ravichandran, Daniel O. Keys, Ali Akcay, Quocan Nguyen, Zhibin He, Alkesh Jani, Danica Ljubanovic and Charles L. Edelstein
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 465-472; DOI: https://doi.org/10.1124/jpet.113.205732

  3. Amant, Frédéric

    1. Fetal Rat Hearts Do Not Display Acute Cardiotoxicity in Response to Maternal Doxorubicin Treatment
      Mina Mhallem Gziri, Peter Pokreisz, Rita De Vos, Eric Verbeken, Frédéric Debiève, Luc Mertens, Stefan P. Janssens and Frédéric Amant
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 362-369; DOI: https://doi.org/10.1124/jpet.113.205419

  4. Andres, Jose Ignacio

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  5. Arnaud, Claire

    1. Anodal Iontophoresis of a Soluble Guanylate Cyclase Stimulator Induces a Sustained Increase in Skin Blood Flow in Rats
      Sylvain Kotzki, Matthieu Roustit, Claire Arnaud, Jean Boutonnat, Sophie Blaise, Diane Godin-Ribuot and Jean-Luc Cracowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 424-431; DOI: https://doi.org/10.1124/jpet.113.205484

  6. Atack, John R.

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  7. Augustin, Ewa

    1. DNA-Damaging Imidazoacridinone C-1311 Induces Autophagy followed by Irreversible Growth Arrest and Senescence in Human Lung Cancer Cells
      Joanna Polewska, Anna Skwarska, Ewa Augustin and Jerzy Konopa
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 393-405; DOI: https://doi.org/10.1124/jpet.113.203851

  8. Bashir, Tarig

    1. The Novel Anticancer Agent JNJ-26854165 Induces Cell Death through Inhibition of Cholesterol Transport and Degradation of ABCA1
      Richard J. Jones, Dongmin Gu, Chad C. Bjorklund, Isere Kuiatse, Alan T. Remaley, Tarig Bashir, Veronique Vreys and Robert Z. Orlowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 381-392; DOI: https://doi.org/10.1124/jpet.113.204958

  9. Beijnen, Jos H.

    1. Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Gene Dosage on Plasma Pharmacokinetics and Brain Accumulation of Dasatinib, Sorafenib, and Sunitinib
      Seng Chuan Tang, Niels de Vries, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen and Alfred H. Schinkel
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 486-494; DOI: https://doi.org/10.1124/jpet.113.205583

  10. Berraondo, Pedro

    1. Modeling Tumor Response after Combined Administration of Different Immune-Stimulatory Agents
      Zinnia P. Parra-Guillen, Pedro Berraondo, Benjamin Ribba and Iñaki F. Trocóniz
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 432-442; DOI: https://doi.org/10.1124/jpet.113.206961
« Previous (Pages : 1 2 3 4 5 6 ... 14) Next »
Back to top

In this issue

Advertisement